Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246623
Status:
COMPLETED
Last Update Posted:
2008-02-08
First Post:
2005-10-28
Brief Title:
US Inhaled Insulin Dose Titration Study
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomized Open-Label Multicenter Study Assessing the Effects of Forced Exubera Dose Titration on Glycemic Control in Patients With Suboptimally Controlled Type 2 Diabetes on Two or More Oral Antidiabetic Agents
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will examine how to dose Exubera inhaled insulin in patients who are not well controlled on two or more diabetes pills This study should show that a large number of patients enrolled in the study can reach the target Hemoglobin A1C levels 7 or less that have been set by the American Diabetes Association ADA Target goals should be achieved by adjusting the Exubera dose either weekly or twice weekly Patients will also receive nutritional counseling and diabetes education as part of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None